Rare Diseases
News
Upcoming vaccine may offset surge in polio subtypes
Response to polio outbreaks involves fast-tracking a modified oral vaccine.
Conference Coverage
Esophageal stricture signals urgent treatment in kids with butterfly skin
LONDON –
Conference Coverage
SCC survival remains poor in epidermolysis bullosa
LONDON – Median survival was 2.4 years in patients with generalized severe recessive dystrophic epidermolysis bullosa after a first diagnosis.
Conference Coverage
Prioritize oral health in children with DEB
LONDON – While it may not be the first thing on the minds of families of children with DEB, it is important to consider oral health early to...
Conference Coverage
Psoriasis ointment helped with itch, healing in phase 2 EB study
LONDON – Low-dose calcipotriol ointment significantly improved wound healing and itch in people with epidermolysis bullosa in a pilot study.
Conference Coverage
Losartan showing promise in pediatric epidermolysis bullosa trial
LONDON – No safety concerns have been seen so far with the antihypertensive drug losartan in children with the skin blistering disease.
Conference Coverage
High cost of wound dressings for epidermolysis bullosa highlighted
LONDON – Dressing and bandage costs were highest for study participants with the generalized severe subtype, at about $112,450 per patient...
From the Journals
Most epidermolysis bullosa patients turn to topical antimicrobials
.
News from the FDA/CDC
Zika virus: Birth defects rose fourfold in U.S. hardest-hit areas
U.S. jurisdictions without local transmission of the virus saw no increase in infants born with brain abnormalities and/or microcephaly or with...
From the Journals
Expedited review programs not shortening drug development
While it may be hard to understand the impact of the many expedited review programs introduced at the FDA, there is still room for improvement in...
Conference Coverage
ADA2 is a potent new biomarker for macrophage activation syndrome
ATLANTA – The hope, first author Dr. Pui Y. Lee said, is that the finding will lead to quicker recognition and treatment of MAS.